Perspective: Advances in liver transplantation for hepatocellular carcinoma-A prototype for transplant oncology

被引：9
作者：
Fung, John [1 ]
DiSabato, Diego [1 ]
Liao, Chih-Yi [1 ]
Ahmed, Osmanuddin [1 ]
Pillai, Anjana [1 ]
机构：
[1] Univ Chicago Med, Liver Tumor Ctr, Chicago, IL 60637 USA
来源：
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL | 2023年 / 22卷 / 01期
关键词：
SURVIVAL;
D O I：
10.1016/j.hbpd.2022.09.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 31 条
[1]   Evolution of liver transplantation in Europe: Report of the European liver transplant registry [J].
Adam, P ;
McMaster, P ;
O'Grady, JG ;
Castaing, D ;
Klempnauer, JL ;
Jamieson, N ;
Neuhaus, P ;
Lerut, J ;
Salizzoni, M ;
Pollard, S ;
Muhlbacher, F ;
Rogiers, X ;
Valdecasas, JCG ;
Berenguer, J ;
Jaeck, D ;
Gonzalez, EM .
LIVER TRANSPLANTATION, 2003, 9 (12) :1231-1243
[2]  
[Anonymous], 1984, HEPATOLOGY, V4, p107S
[3]   Global Burden of 5 Major Types of Gastrointestinal Cancer [J].
Arnold, Melina ;
Abnet, Christian C. ;
Neale, Rachel E. ;
Vignat, Jerome ;
Giovannucci, Edward L. ;
McGlynn, Katherine A. ;
Bray, Freddie .
GASTROENTEROLOGY, 2020, 159 (01) :335-+
[4]  
AstraZeneca, IMF PLUS TREM SIGN I
[5]   Comparison between Milan and UCSF criteria for liver transplantation in patients with hepatocellular carcinoma: a systematic review and meta-analysis [J].
Bento de Sousa, Jorge Henrique ;
Calil, Igor Lepski ;
Tustumi, Francisco ;
Khalil, Douglas da Cunha ;
Goncalves Felga, Guilherme Eduardo ;
de Arruda Pecora, Rafael Antonio ;
de Almeida, Marcio Dias .
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 6
[6]  
Calne RY, 1987, ANN CLIN RES, V2nd
[7]   Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma [J].
Chew, Valerie ;
Lee, Yun Hua ;
Pan, Lu ;
Nasir, Nurul J. M. ;
Lim, Chun Jye ;
Chua, Camillus ;
Lai, Liyun ;
Hazirah, Sharifah Nur ;
Lim, Tony Kiat Hon ;
Goh, Brian K. P. ;
Chung, Alexander ;
Lo, Richard H. G. ;
Ng, David ;
Filarca, Rene L. F. ;
Albani, Salvatore ;
Chow, Pierce K. H. .
GUT, 2019, 68 (02) :335-346
[8]   Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma [J].
Finn, Richard S. ;
Qin, Shukui ;
Ikeda, Masafumi ;
Galle, Peter R. ;
Ducreux, Michel ;
Kim, Tae-You ;
Kudo, Masatoshi ;
Breder, Valeriy ;
Merle, Philippe ;
Kaseb, Ahmed O. ;
Li, Daneng ;
Verret, Wendy ;
Xu, Derek-Zhen ;
Hernandez, Sairy ;
Liu, Juan ;
Huang, Chen ;
Mulla, Sohail ;
Wang, Yulei ;
Lim, Ho Yeong ;
Zhu, Andrew X. ;
Cheng, Ann-Lii .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) :1894-1905
[9]   The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer [J].
Flynn, Michael J. ;
Hartley, John A. .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (01) :20-35
[10]   Systematic review with meta-analysis: sirolimus-or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma [J].
Grigg, Sam E. ;
Sarri, Gino L. ;
Gow, Paul J. ;
Yeomans, Neville D. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (10) :1260-1273
1234